Article info
Clinical and epidemiological research
Extended report
Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial
- Correspondence to Laura Louise Laslett, University of Tasmania, Menzies Research Institute Tasmania, Private Bag 23, Hobart, Tasmania, Australia, 7000; Laura.Laslett{at}utas.edu.au
Citation
Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial
Publication history
- Received October 27, 2011
- Accepted December 21, 2011
- First published February 21, 2012.
Online issue publication
July 14, 2012
Article Versions
- Previous version (21 February 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions